Pancreatic -cell mass is significantly reduced by more than 50% in patients with T2DM, with lesser reductions already occurring in the prediabetes state (124)
Tirzepatide, by contrast, is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Therefore, excessive adiposity (obesity) is caused by energy intake in excess of energy output
Clin Gastroenterol Hepatol 15:96102 e103 Ratziu V (2017) Non-pharmacological interventions in non-alcoholic fatty liver disease patients
But when I hear clinicians talk about this and who the kinds of conversations they have with patients it sort of comes back to that earlier conversation we had where I'll hear the phrase a lot: you know, they've got this BMI or this obesity and they've tried everything else and it hasn't worked and now we're going to talk about the pharmaceutical
To learn more about how you can partner with Wellstar rehabilitation care teams to reduce your risk of another stroke, visit Keep reading Published on: May 28, 2024 Wellstar Transforms Patient Check-in with CLEAR Wellstar and CLEAR are launching an initiative that simplifies and speeds up the patient check-in process
